Zobrazeno 1 - 3
of 3
pro vyhledávání: '"J. Gerry Everlof"'
Autor:
Ivar M. McDonald, Wang Nenghui, Victor R. Guarino, Kimberley A. Lentz, Richard E. Olson, Wendy Clarke, Roy Haskell, J. Gerry Everlof
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(3)
The objective of this Letter is to report the first (to our knowledge) in vivo proof of concept for a sulfenamide prodrug to orally deliver a poorly soluble drug containing a weakly-acidic NH–acid from a conventional solid dosage formulation. This
Autor:
Carl P. Decicco, Meizhong Xu, Rui-Qin Liu, Yvonne C. Lo, Percy H. Carter, Lorin A. Thompson, James M. Trzaskos, Gengjie Yang, Andrew J. Tebben, J. Gerry Everlof, Paul Strzemienski, Peggy A. Scherle, Gregory D. Brown, Matthew E. Voss
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:533-538
Based on the realization that N-alkyl 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones are tumor necrosis factor-alpha antagonists, we discovered two additional classes of antagonists: 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones (via rational desig
Autor:
C. M. Foris, Shelley R. Rabel, G. Creston Campbell, Gregory A. Nemeth, Susan M. Rowe, Michael B. Maurin, J. Gerry Everlof, Rodney Vickery
Publikováno v:
Journal of Pharmaceutical Sciences. 91:2599-2604
Roxifiban was found to exist in two polymorphic forms. The polymorphs were detected by X-ray powder diffraction and solid-state carbon nuclear magnetic resonance. A slight difference between the two polymorphs was also detected by isothermal microcal